Market Outlook

By 2035, the U.S. Aging-in-Place Medical Devices Market is expected to reach approximately USD 86.96 billion, expanding at a CAGR of 9.45% during the forecast period 2026–2035. The market is estimated at USD 35.25 billion in 2025, following expansion from approximately USD 24.70 billion in 2021, USD 27.02 billion in 2022, USD 29.59 billion in 2023, and USD 32.30 billion in 2024. Values in this report are expressed in USD billions.

The U.S. aging-in-place medical devices industry is developing into a strategically important intersection of medical technology, durable medical equipment, remote patient monitoring, home healthcare, senior safety, mobility support, chronic disease management, and consumer-directed health technology. Its growth is being driven not simply by population aging, but by a structural change in where older Americans want to receive care and where healthcare organizations increasingly need to deliver it.

More than 61 million Americans were age 65 or older by 2024, creating a large and expanding addressable population for technologies that extend safe independent living. At the same time, three-quarters of Americans age 50 and above indicate a preference to remain in their existing homes as they age. These demographic and behavioral forces create persistent demand for mobility devices, fall-detection systems, personal emergency response systems, home monitoring devices, respiratory equipment, glucose and cardiovascular monitoring technologies, patient-transfer systems, medication-support devices, accessible therapeutic equipment, and connected care platforms.

The value proposition for aging-in-place technology has also changed. Historically, many products were purchased primarily by individuals or family caregivers as isolated pieces of equipment. Increasingly, medical devices deployed in the home are becoming part of organized clinical pathways involving health systems, physician practices, Medicare Advantage organizations, home health agencies, accountable care organizations, Medicaid programs, and post-acute providers.

The market is expected to accelerate from approximately USD 38.58 billion in 2026 to USD 55.37 billion by 2030, before reaching USD 86.96 billion in 2035. Growth will increasingly concentrate in devices that combine clinical monitoring with connectivity, automated fall detection, caregiver escalation, passive sensing, simple user interfaces, remote configuration, and integration with healthcare workflows.

For manufacturers, the commercial opportunity is therefore moving beyond selling equipment into the home. The stronger long-term position will belong to companies that can demonstrate that their devices reduce preventable utilization, extend functional independence, improve adherence, lower caregiver burden, and allow clinical teams to manage larger populations outside institutional settings.

 

Introduction

According to the U.S. Aging-in-Place Medical Devices Market Report, aging in place refers to an individual’s ability to remain safely and functionally independent in a private home or community setting despite advancing age, chronic illness, mobility limitation, sensory impairment, or increasing need for clinical supervision.

For the purpose of this report, the market includes medical and medically oriented devices whose principal value is enabling older adults to remain outside hospitals, skilled nursing facilities, or higher-acuity institutional care for longer periods. The scope includes connected patient monitoring equipment, mobility and transfer devices, fall-detection and emergency-response technologies, respiratory and therapeutic home equipment, chronic disease monitoring devices, medication-support technologies, selected assistive devices, and clinically integrated sensor systems.

The report excludes general home renovation, conventional consumer electronics without a meaningful healthcare function, nonmedical furniture, caregiver labor, home health service revenue, pharmaceuticals, and the cost of residential construction. This distinction is important because the aging-in-place economy is considerably broader than the medical-device opportunity addressed in this market assessment.

The addressable market is strengthened by the underlying structure of the U.S. senior population. Older adults have a high prevalence of cardiovascular disease, diabetes, arthritis, chronic respiratory disease, impaired balance, vision limitations, neurological disease, and multiple chronic conditions. These conditions increase demand for devices that support mobility, physiological monitoring, emergency response, rehabilitation, respiratory therapy, medication management, and daily living.

Falls represent one of the clearest clinical and economic problems supporting market adoption. More than 14 million adults age 65 and above report falling in a typical year. Fall events can trigger emergency department utilization, fractures, traumatic brain injury, hospitalization, rehabilitation, and loss of independence. As a result, fall prevention and rapid emergency detection are increasingly viewed as healthcare-management issues rather than solely household safety concerns.

Another important market characteristic is the growth of Medicare and Medicare Advantage. Medicare enrollment now exceeds 70 million beneficiaries, with the overwhelming majority age 65 or above. Greater penetration of managed Medicare creates a stronger economic incentive to identify technologies capable of reducing downstream medical expenditure, avoidable emergency utilization, readmissions, and institutional care.

Aging-in-place devices therefore sit at the intersection of consumer preference and payer economics. Older Americans want independence, families need scalable caregiving support, health systems need capacity outside hospital walls, and payers need lower-cost alternatives to preventable acute and institutional care.

 

Key Market Drivers: What’s Fueling the U.S. Aging-in-Place Medical Devices Market Boom?

The most fundamental growth driver is the increasing scale of the U.S. older population. Approximately 61.25 million Americans were age 65 or older in 2024, and older adults now represent a much larger share of the population than they did two decades ago. The demographic effect will persist well beyond the forecast period as the large baby-boomer population advances into higher-acuity age bands.

A critical point for device manufacturers is that aging does not create one uniform medical-device requirement. Adults in their late sixties may primarily require connected blood pressure monitors, glucose sensors, sleep therapy devices, or early mobility support. Adults in their eighties and nineties are more likely to require fall detection, walkers, wheelchairs, patient-transfer systems, respiratory equipment, pressure-management products, medication assistance, emergency response systems, and caregiver monitoring. Consequently, the market expands not only because the number of older adults is increasing, but because a growing proportion is moving into age groups associated with greater functional dependency.

A second major driver is the strong preference to remain at home. Approximately 75% of Americans age 50 and above want to remain in their existing homes as they age, while approximately 73% want to remain within their existing communities. This preference is commercially significant because it converts longevity into demand for technologies that make independent living realistically sustainable.

The home, however, was not originally designed as a clinical environment. Successful aging in place therefore requires medical technology that can function reliably outside controlled hospital infrastructure. Devices must accommodate limited digital literacy, declining dexterity, reduced vision or hearing, inconsistent connectivity, caregiver involvement, and patients managing several conditions simultaneously.

The third major driver is the economic burden of falls and functional decline. More than one in four older adults report a fall each year, with millions requiring medical care or experiencing activity limitation. Falls can become the event that changes an older adult from independent living to hospitalization, rehabilitation, assisted living, or long-term institutional care. This gives automatic fall detection, gait monitoring, emergency-response wearables, transfer aids, mobility support, bathroom safety equipment, and passive monitoring systems an economic relevance that exceeds their purchase price.

A fourth growth driver is the rising burden of chronic disease management in the home. Older adults commonly manage hypertension, heart disease, diabetes, chronic obstructive pulmonary disease, sleep apnea, heart failure, osteoarthritis, arrhythmias, and other long-duration conditions. Devices increasingly allow these patients to measure blood pressure, glucose, oxygen saturation, weight, respiratory status, cardiac rhythm, sleep metrics, and other parameters without frequent facility-based encounters.

This transition is particularly important for health systems attempting to create longitudinal care models. A connected blood pressure monitor is more valuable when elevated readings enter a clinical workflow and trigger medication adjustment. A pulse oximeter becomes more useful when deteriorating respiratory status generates meaningful escalation. A weighing scale becomes clinically relevant when rapid weight gain identifies possible fluid retention in a heart failure patient.

The fifth driver is the continued migration of healthcare expenditure into home and post-acute settings. Hospitals face persistent pressure around capacity, workforce shortages, avoidable admissions, readmissions, and discharge delays. Earlier discharge increases the importance of reliable medical devices in the home because patients may still require monitoring, respiratory support, wound management, mobility assistance, rehabilitation, or medication supervision after leaving institutional care.

Home health payment policy also creates pressure for efficiency. U.S. home health organizations operate under reimbursement constraints and increasingly need equipment that reduces unnecessary visits while helping clinical teams prioritize patients most likely to deteriorate. Connected and remotely configurable devices can improve this operating model when data are actionable and false-alert burden is controlled.

The sixth driver is caregiver scarcity. Aging in place often depends on spouses, adult children, neighbors, or paid home-care workers. As the number of older adults increases faster than the available caregiving workforce, technology becomes an important force multiplier. Passive motion sensing, automated fall alerts, remote medication reminders, GPS-enabled emergency devices, caregiver applications, connected vital-sign equipment, and remote patient monitoring platforms can reduce the need for continuous physical observation.

The seventh driver is the maturation of Medicare Advantage and value-oriented reimbursement. Managed-care organizations carry more direct exposure to the total healthcare cost of their enrolled populations. Technologies that help prevent an emergency department visit, identify deterioration before hospitalization, improve medication adherence, or delay institutional placement can therefore create measurable economic value.

The final major driver is improving senior usability. Earlier generations of home health technology were often fragmented, difficult to configure, visually complex, or dependent on the patient performing multiple digital steps. Newer products increasingly use cellular connectivity, automatic data transmission, simplified charging, voice interaction, larger displays, wearable sensors, background monitoring, and preconfigured kits.

For aging-in-place devices, usability is not a secondary product-design issue. A clinically advanced device that an 82-year-old patient cannot operate consistently has limited economic value. Human-factors engineering, caregiver accessibility, and installation support will therefore become increasingly important competitive differentiators through 2035.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. aging-in-place medical devices market is shifting from individual products toward connected systems that understand both clinical status and functional behavior. The next competitive cycle will be defined by technologies that can detect deterioration without requiring constant active input from older users.

Continuous and passive sensing is one of the most important areas of development. Wearable patches and compact sensor platforms can now monitor combinations of heart rate, respiratory rate, temperature, movement, body position, sleep, gait, and activity. For older adults, this creates the possibility of detecting declining function before a major event occurs.

Fall detection is also moving beyond the traditional pendant button. Accelerometers, gyroscopes, GPS, cellular connectivity, room sensors, wearable algorithms, and activity-pattern analysis increasingly allow devices to identify potential falls automatically. This is particularly important because the person experiencing a fall may be unconscious, confused, injured, separated from a phone, or physically unable to press a button.

Another major innovation cycle is occurring in home-based chronic disease monitoring. Continuous glucose monitoring is increasingly accessible outside traditional insulin-dependent populations. Connected blood pressure monitors, pulse oximeters, ECG-capable wearables, smart scales, respiratory devices, and home diagnostic tools are also becoming easier to integrate into longitudinal care programs.

Mobility technology is simultaneously becoming more personalized. Lightweight wheelchairs, power mobility systems, pressure-relieving seating, advanced prosthetic and orthotic technologies, powered transfer systems, ergonomic walkers, and configurable mobility platforms can improve independence while reducing caregiver injury.

Respiratory and sleep technologies are also evolving toward connected care. CPAP and bilevel systems increasingly transmit adherence and performance information remotely. Home oxygen technologies continue to improve in portability and battery performance. Connected respiratory systems can help clinicians determine whether a patient is using therapy correctly and whether intervention is needed.

Artificial intelligence will increasingly function as an interpretation layer rather than a standalone aging-in-place product. The commercial value of AI lies in transforming thousands of readings into prioritized clinical signals. For healthcare organizations managing large home populations, systems that identify meaningful changes in mobility, vital signs, medication adherence, or daily routine may reduce monitoring burden.

Manufacturers are therefore competing on more than sensor accuracy. The strongest products increasingly combine clinical-grade measurement, minimal patient interaction, dependable connectivity, caregiver accessibility, EHR interoperability, escalation logic, technical support, and health-economic evidence.

 

Segmentation Insights

The U.S. Aging-in-Place Medical Devices Market is segmented on the basis of product category, application, end user, technology type, and region.

 

By Product Category

Connected Monitoring and Chronic-Care Devices

Connected monitoring and chronic-care devices represent one of the most strategically important product groups. The segment includes blood pressure monitors, glucose monitoring systems, pulse oximeters, ECG and cardiac monitoring devices, connected scales, wearable physiological sensors, digital thermometers, selected home diagnostic systems, and monitoring gateways.

Demand is being driven by hypertension, diabetes, heart failure, arrhythmia, chronic respiratory disease, and the broader movement toward remote clinical management. The strongest commercial opportunities exist where device data feed directly into clinical decision-making rather than remaining isolated in consumer applications.

Mobility, Transfer, and Positioning Devices

Mobility and transfer devices form a large and durable market segment and include manual wheelchairs, power wheelchairs, scooters, walkers, rollators, canes, transfer aids, patient lifts, pressure-relief seating, positioning systems, and selected home mobility accessories.

Growth is supported by arthritis, stroke, neurological disease, frailty, post-operative recovery, balance impairment, and age-related muscle loss. Products that preserve independence while reducing caregiver lifting requirements are likely to receive particularly strong demand.

The segment has a significant replacement component because mobility requirements change over time. A patient may progress from a cane to a walker, from a walker to a manual wheelchair, and ultimately to powered mobility or more sophisticated seating and positioning equipment.

Fall Detection and Personal Emergency Response Devices

Fall detection and PERS technologies constitute one of the most recognizable aging-in-place categories. Traditional home-base emergency buttons are increasingly being supplemented by mobile cellular devices, GPS-enabled wearables, smartwatches, automatic fall-detection systems, room-based sensors, and caregiver applications.

The economic rationale is strong because delayed assistance after a fall can materially worsen outcomes. Devices that combine emergency response with location detection, two-way communication, passive monitoring, and caregiver engagement are expected to outperform basic alarm-only products.

Home Respiratory and Therapeutic Devices

Home respiratory and therapeutic equipment includes CPAP systems, bilevel ventilation devices, oxygen concentrators, nebulizers, airway-clearance technologies, selected ventilatory support devices, home infusion equipment, pressure-management products, and other therapeutic systems used outside institutional care.

The aging population has substantial exposure to sleep apnea, COPD, cardiopulmonary disease, and chronic respiratory impairment. Portable equipment and remotely connected therapy platforms support both independence and earlier discharge from institutional care.

Medication, Daily-Living, and Safety Support Devices

This category includes connected medication dispensers, medication reminder systems, selected smart pill devices, bathroom safety products, bedside support equipment, pressure-management products, transfer-related safety devices, and other equipment designed to compensate for declining functional ability.

The category is fragmented but strategically important because medication errors, poor adherence, bathroom falls, difficulty transferring, and inability to perform activities of daily living are major contributors to loss of independence.

 

By Application

Fall Prevention and Emergency Response

Fall prevention and emergency response represent a core aging-in-place application because a single serious fall can permanently alter a patient’s ability to live independently. Devices supporting this application include wearables, automatic fall detectors, mobility aids, transfer devices, balance-support products, patient lifts, pressure-management systems, and emergency communication technologies.

Demand is highest among adults with previous falls, gait instability, neurological disease, impaired vision, polypharmacy, osteoporosis, and advanced frailty.

Chronic Disease Monitoring and Management

Chronic disease management represents the highest-growth application area. Blood pressure monitoring, glucose sensing, cardiac monitoring, pulse oximetry, weight monitoring, respiratory therapy, and connected diagnostic equipment allow older adults with multiple chronic diseases to remain clinically visible while living at home.

Healthcare organizations increasingly evaluate these technologies based on their ability to identify deterioration, reduce unnecessary visits, improve adherence, and prevent high-cost acute episodes.

Mobility and Activities-of-Daily-Living Support

Mobility support includes devices that preserve walking, transfers, bathing, toileting, positioning, and movement around the home. Clinical demand ranges from relatively simple walkers to highly customized power mobility and patient-transfer systems.

The value of these products is strongly connected to independence. Even when the underlying disease cannot be reversed, appropriate assistive technology can preserve the patient’s ability to perform activities necessary for community living.

Post-Acute Recovery and Home Rehabilitation

Older patients increasingly recover from orthopedic surgery, cardiovascular procedures, stroke, hospitalization, and other acute episodes at home. This creates demand for mobility support, monitoring equipment, respiratory devices, rehabilitation technologies, wound-related equipment, and patient-transfer systems.

The application is particularly important to hospitals because inadequate equipment at discharge can increase the risk of falls, treatment nonadherence, readmission, and delayed recovery.

Cognitive, Medication, and Caregiver Support

Patients with mild cognitive impairment, dementia, complex medication schedules, or declining executive function often require a different technology model. The most useful devices reduce reliance on memory and provide caregivers with visibility into adherence or abnormal behavior.

Connected medication dispensing, location technologies, passive movement monitoring, emergency response devices, and caregiver alert systems are expected to gain importance as dementia prevalence and caregiver burden rise.

 

By End User

Older Adults Living Independently and Family Caregivers

Home-based older adults and their caregivers represent the market’s largest ultimate user population. Purchasing decisions are influenced by clinical need, reimbursement availability, ease of installation, monthly service fees, caregiver confidence, product reliability, and the older adult’s willingness to use the device consistently.

Direct-to-consumer channels are particularly important in PERS, mobility aids, connected monitoring, and selected daily-living support technologies.

Home Health Agencies and Post-Acute Providers

Home health organizations use aging-in-place devices to support skilled nursing, rehabilitation, chronic disease management, post-discharge monitoring, and functional recovery. These buyers emphasize operational simplicity because clinicians may manage large geographically dispersed patient panels.

Devices that automatically transmit reliable information and require minimal setup can reduce staff burden. Equipment suppliers that provide logistics, cleaning, installation, retrieval, training, and technical support can create additional value.

Hospitals, Health Systems, and Physician Groups

Health systems increasingly extend clinical management beyond the hospital through remote patient monitoring, transitional care, chronic care management, and home-based acute or post-acute programs.

These organizations prioritize interoperability, clinical validation, cybersecurity, alarm management, integration with EHR workflows, and measurable reductions in utilization. Procurement decisions therefore resemble enterprise technology purchases rather than conventional consumer-device buying.

Medicare Advantage, Medicaid, and Managed-Care Organizations

Managed-care organizations are becoming increasingly influential purchasers or sponsors of aging-in-place technology because they carry financial risk for emergency visits, hospital admissions, and other healthcare utilization.

PERS benefits, connected monitoring, mobility support, and selected home-safety technologies can be economically attractive when deployed to carefully risk-stratified populations. The key procurement question is whether the device changes measurable outcomes rather than simply increasing member engagement.

Senior Living, Community-Based Care, and Aging Services Organizations

Independent living communities, senior housing organizations, community care programs, aging-service networks, and other non-hospital organizations represent another important channel.

These users often need scalable systems capable of supporting emergency response, fall detection, mobility, medication adherence, and caregiver coordination without transforming the setting into an institutional medical environment.

 

By Technology Type

Non-Connected Mechanical and Assistive Technologies

Non-connected devices remain a substantial portion of the market. Wheelchairs, walkers, patient lifts, transfer products, bathroom-support devices, seating systems, and other mechanically oriented products provide dependable functional value without requiring digital infrastructure.

This category will grow more slowly than connected technology but will remain essential because mobility impairment and physical assistance cannot be addressed through software alone.

Sensor-Based and Passive Monitoring Technologies

Sensor-based systems represent one of the fastest-growing technology categories. These devices use motion sensing, accelerometers, pressure sensors, environmental sensing, physiological sensors, and related technologies to identify changes without requiring frequent patient interaction.

Passive monitoring is particularly attractive for frail or cognitively impaired adults who may not consistently enter data into an app.

Wearable Medical and Safety Devices

Wearables include physiological patches, mobile PERS devices, fall-detection wearables, glucose sensors, ambulatory ECG technologies, and other body-worn devices.

Commercial success depends heavily on comfort and adherence. Smaller form factors, longer battery life, waterproofing, cellular connectivity, and simplified charging will increasingly differentiate products.

Connected Clinical Monitoring Technologies

Connected clinical systems transmit patient-generated health data to clinicians, caregivers, or monitoring centers. This category includes cellular or Bluetooth blood pressure systems, connected scales, pulse oximeters, respiratory devices, glucose monitors, cardiac monitoring systems, and multi-parameter monitoring kits.

Growth is supported by the expansion of remote care programs, but buyers increasingly demand interoperability and workflow integration rather than standalone dashboards.

AI-Assisted and Predictive Aging-in-Place Technologies

AI-enabled technologies represent an emerging high-growth layer. Algorithms can analyze combinations of vital signs, gait, activity, sleep, medication behavior, and historical patterns to identify changes that may indicate elevated risk.

The primary commercial challenge will be proving clinical utility. Health systems will increasingly differentiate between analytics that generate additional alarms and analytics that meaningfully improve clinical prioritization.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Aging-in-Place Medical Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance differs considerably because aging-in-place demand is influenced by the absolute size of the senior population, percentage of older residents, Medicare enrollment, rurality, chronic disease burden, household income, housing structure, health-system concentration, home health availability, and adoption of connected medical technology.

The South is the largest regional market in 2025, while the West is expected to record the fastest growth through 2035. The Northeast represents a high-value market with sophisticated health-system procurement, while the Midwest provides a large and stable base for mobility, home respiratory, monitoring, and chronic-care devices.

South

The South represents an estimated USD 11.99 billion market in 2025 and is forecast to reach approximately USD 30.18 billion by 2035, representing an implied CAGR of approximately 9.7%.

The region includes Alabama, Arkansas, Delaware, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia. Washington, D.C., while not a state, also contributes to regional healthcare demand.

The South benefits from the largest combined population base of the four U.S. regions and contains several of the country’s fastest-growing senior markets. It also has substantial prevalence of diabetes, cardiovascular disease, obesity, respiratory disease, and functional limitation, supporting demand for connected chronic-care devices, mobility products, respiratory systems, and home monitoring.

Florida is the region’s most strategically important aging-in-place market. Its 2024 population included more than 5 million adults age 65 or above. The combination of large senior communities, high Medicare enrollment, extensive home health infrastructure, retirement migration, and substantial independent-living housing creates an unusually dense customer base for PERS, mobility, respiratory, glucose monitoring, home diagnostics, and caregiver-support technologies.

Florida is particularly attractive for companies that can distribute through Medicare Advantage plans, DME suppliers, physician groups, senior living operators, home health agencies, and direct-to-consumer channels simultaneously.

Texas provides a different opportunity. Its senior share of population is lower than Florida’s, but its enormous absolute population, rapid growth, major metropolitan health systems, and expanding suburban senior population create significant device demand. Houston, Dallas-Fort Worth, San Antonio, and Austin support large integrated delivery networks capable of deploying remote monitoring and home-care technology at enterprise scale.

North Carolina and Georgia are increasingly important due to population growth and migration of older residents. Both states combine major academic systems with expanding suburban and retirement populations. Connected cardiovascular monitoring, diabetes technology, mobility products, home respiratory equipment, and fall-detection platforms have strong growth potential.

Virginia and Maryland benefit from relatively high household income, sophisticated provider networks, and technology-oriented health systems. These markets are favorable for digitally connected products where adoption requires reliable broadband, smartphone use, caregiver engagement, and health-system integration.

Tennessee, Kentucky, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, and West Virginia present a different commercial profile. Chronic disease burden and functional need can be high, but rural access, lower household income, workforce shortages, and uneven specialist access influence purchasing.

For these states, aging-in-place technologies can create especially meaningful healthcare value when they reduce travel requirements or support remote supervision. However, manufacturers must account for affordability, cellular coverage, DME reimbursement, technical support, and simple device operation.

The South is expected to remain the largest region throughout the forecast period because it combines large-scale population growth with one of the country’s biggest concentrations of older adults.

West

The West accounted for an estimated USD 8.81 billion in 2025 and is projected to reach approximately USD 23.91 billion by 2035, representing an implied CAGR of approximately 10.5%, the fastest of the four U.S. regions.

The West includes Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming.

The region has two important structural advantages: rapid senior-population growth in several states and strong adoption of connected healthcare technologies.

California is the largest aging-in-place device market in the West and one of the largest individual state opportunities nationally. The state had more than 6 million adults age 65 and above by the early 2020s. Its market combines enormous scale with advanced provider infrastructure, medical technology innovation, venture-backed digital health development, and substantial Medicare and managed-care enrollment.

California health systems are particularly influential in remote monitoring, connected diabetes management, virtual care, hospital-at-home infrastructure, and AI-enabled clinical workflow. Manufacturers seeking early clinical evidence or enterprise adoption frequently view California providers as important launch partners.

Arizona is one of the most attractive senior-growth markets because of retirement migration, a relatively high share of older residents, and population growth in Phoenix, Tucson, and surrounding communities. Demand is especially strong for mobility products, cardiac and diabetes monitoring, respiratory equipment, PERS, and caregiver-support technology.

Nevada, Idaho, Utah, and Colorado have experienced strong population growth and are increasingly relevant to aging-in-place suppliers. Idaho’s older population grew particularly rapidly over the previous decade, highlighting the need to expand home and community care infrastructure as retirement-aged populations migrate into historically smaller healthcare markets.

Washington and Oregon provide sophisticated health-system markets where integrated delivery networks, remote patient management, and connected care technologies are comparatively well established. Device suppliers capable of integrating into enterprise clinical platforms can perform strongly in these states.

Montana, Wyoming, Alaska, and New Mexico have smaller absolute populations but present an important use case for remote care. Long travel distances, specialist scarcity, and dispersed communities create strong clinical logic for connected monitoring, portable respiratory systems, emergency-response technology, and caregiver escalation.

Hawaii combines a relatively high older-population share with geographic isolation. Portable medical equipment, connected chronic-care systems, and technologies that reduce unnecessary travel between islands can provide meaningful value.

The West is expected to gain national share through 2035 as aging-in-place technology becomes more connected, predictive, software-supported, and integrated with population-health models.

Northeast

The Northeast represented an estimated USD 7.76 billion in 2025 and is expected to reach approximately USD 17.91 billion by 2035, implying growth of approximately 8.7% annually.

The region includes Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont.

Although its population is growing more slowly than the South and West, the Northeast is a premium market because of high healthcare intensity, significant academic medical infrastructure, strong specialist density, large Medicare populations, and sophisticated procurement.

New York is the largest state opportunity in the region. Its high population density produces significant volumes of chronic disease management, mobility equipment, post-acute care, and home monitoring. New York City creates strong demand for compact mobility equipment and home-based devices suited to smaller living environments, while upstate markets create greater need for remote access technologies.

Pennsylvania has one of the country’s largest senior populations and a large network of academic and community healthcare systems. Its aging demographic supports sustained demand for mobility, respiratory, cardiac monitoring, diabetes technologies, PERS, and post-acute equipment.

New Jersey combines high population density, significant Medicare penetration, strong household purchasing power, and proximity to major health-system markets in both New York and Philadelphia.

Massachusetts is strategically influential beyond its population size. The state contains major academic institutions, biomedical research organizations, digital health companies, and innovative provider systems. It is therefore an important early-adoption market for remote monitoring, wearable sensors, predictive analytics, and integrated home-care platforms.

Connecticut, Rhode Island, and New Hampshire provide smaller but relatively high-value markets where aging populations and higher household incomes support premium home medical technology.

Maine and Vermont are particularly important from a demographic perspective because they rank among the states with the highest percentage of residents age 65 and above. Their rural geographies also reinforce the need for connected monitoring, emergency response, home respiratory equipment, and mobility support.

The Northeast will remain an attractive market for manufacturers with clinically differentiated, evidence-backed products. Procurement is likely to become increasingly rigorous, however, as health systems seek proof that connected devices improve outcomes and reduce total care costs.

Midwest

The Midwest represented approximately USD 6.69 billion in 2025 and is forecast to reach about USD 14.96 billion by 2035, representing an implied CAGR of approximately 8.4%.

The region includes Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin.

The Midwest provides a durable demand base built around large older populations, mature hospital systems, strong DME distribution, significant chronic disease prevalence, and extensive rural healthcare networks.

Illinois, Ohio, and Michigan are the region’s largest markets. Chicago gives Illinois a major academic and integrated-care ecosystem, while Ohio contains several nationally influential health systems capable of deploying remote monitoring and post-acute technology at scale. Michigan has a large senior population and significant demand for cardiovascular, diabetes, mobility, and respiratory devices.

Minnesota has outsized strategic importance because of its medical-device ecosystem and history of healthcare innovation. The state provides an attractive environment for connected monitoring, cardiovascular technology, mobility solutions, and new models of home care.

Wisconsin, Indiana, and Missouri represent sizeable middle-market opportunities with large community healthcare networks and consistent demand for DME, home respiratory equipment, mobility technology, and chronic disease monitoring.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota are smaller by population but important for aging-in-place because many older adults live far from major medical centers. Connected devices that reduce travel while maintaining clinical oversight have particularly strong relevance.

The Midwest is unlikely to match the West’s technology-led growth rate, but its large installed base of older adults, mature DME channels, and substantial rural population make it an important long-term market.

 

Key Market Players

The U.S. Aging-in-Place Medical Devices Competitive Landscape is fragmented across conventional medtech companies, DME manufacturers, mobility specialists, diabetes and chronic-disease technology companies, remote monitoring developers, and personal emergency response providers.

Competition is increasingly moving toward integrated ecosystems. A mobility company can succeed through superior biomechanics and customization, while a digital monitoring company must compete through connectivity, clinical integration, and analytics. PERS companies increasingly compete on automatic detection, cellular reliability, response-center quality, managed-care partnerships, and caregiver engagement.

Some of the key players relevant to the U.S. Aging-in-Place Medical Devices industry include:

Abbott Laboratories
Medtronic
Dexcom
ResMed
Baxter International
Koninklijke Philips
Masimo
OMRON Healthcare
Insulet Corporation
Drive DeVilbiss Healthcare
Invacare
Sunrise Medical
Permobil
Pride Mobility Products
Stryker
Arjo
Savaria
Connect America
Medical Guardian
ADT Health
Tunstall Healthcare
Best Buy Health/Lively
BioIntelliSense
Withings Health Solutions

Abbott, Dexcom, Insulet, Medtronic, OMRON, Masimo, ResMed, and Philips are positioned around chronic disease monitoring and therapeutic home care. Their advantages include clinical evidence, physician familiarity, reimbursement experience, regulatory capabilities, and established healthcare distribution.

Drive DeVilbiss, Invacare, Sunrise Medical, Permobil, Pride Mobility, Arjo, Stryker, and Savaria compete more heavily across mobility, transfers, rehabilitation, positioning, and physical independence. Their commercial strength depends on dealer relationships, customization, service infrastructure, ergonomics, durability, and reimbursement navigation.

Medical Guardian, Connect America, ADT Health, Tunstall, and Lively represent an increasingly sophisticated emergency-response and senior-safety ecosystem. Their competitive models combine hardware with monitoring subscriptions, service centers, caregiver software, fall detection, GPS, cellular connectivity, and payer or senior-care partnerships.

BioIntelliSense and Withings Health Solutions reflect the convergence between conventional devices and remote population management. Their opportunity lies in converting home-generated data into clinically manageable information.

Market share through 2035 will increasingly be influenced by the ability to sell beyond individual devices. Manufacturers that provide logistics, setup, connectivity, patient engagement, caregiver access, reimbursement support, software integration, and outcomes evidence can capture a larger proportion of the aging-in-place value chain.

 

Recent Developments

Recent activity in the U.S. aging-in-place medical devices ecosystem demonstrates how quickly the boundary between traditional DME, consumer health technology, and regulated remote monitoring is changing.

In 2024, the FDA cleared Dexcom’s Stelo glucose biosensor system, expanding access to continuous glucose information without requiring the conventional prescription-based pathway associated with earlier generations of CGM. Greater availability of simplified glucose sensing is strategically relevant to aging in place because type 2 diabetes is highly prevalent among older adults and requires substantial self-management.

Abbott also advanced its U.S. sensor portfolio in 2024 with FDA clearances involving the Lingo and Libre Rio glucose monitoring systems. The broader direction of the market is toward less invasive, lower-friction monitoring technologies that can be used outside specialist-centered clinical workflows.

Sensor-based remote monitoring continued to progress beyond glucose. FDA-cleared technologies increasingly include wearable systems capable of collecting heart rate, respiratory rate, temperature, activity, body position, and related data in home settings. These systems support a transition from episodic measurements toward continuous observation of higher-risk patients.

The PERS market also experienced meaningful consolidation. In May 2024, Medical Guardian acquired MobileHelp, expanding its scale across personal emergency response, remote monitoring, location tracking, and healthcare engagement. The transaction illustrates how senior-safety providers are attempting to move beyond emergency buttons toward broader aging-in-place platforms.

Best Buy Health introduced the Lively Mobile2 in 2024, emphasizing improved fall detection and access to a staffed emergency-response network. The product direction demonstrates ongoing convergence between consumer-friendly industrial design and dedicated senior-safety infrastructure.

Home-care reimbursement remains more complicated. CMS’s CY 2025 Home Health Prospective Payment System final rule resulted in an estimated aggregate Medicare home health payment increase of only approximately 0.5% versus 2024 after multiple adjustments. For device suppliers, this illustrates an important market constraint: home health providers need innovation but remain cost-sensitive.

Consequently, manufacturers cannot assume that technology adoption will follow clinical attractiveness alone. New devices increasingly need to demonstrate measurable operational leverage, fewer unnecessary visits, improved adherence, lower adverse-event risk, or a credible reduction in downstream utilization.

Recent strategic activity also shows that the care-at-home model remains commercially demanding. Technology suppliers must solve logistics, patient setup, connectivity, monitoring labor, EHR integration, device retrieval, technical support, and reimbursement simultaneously. The next stage of market development will reward platforms that solve these operational issues alongside device innovation.

 

Conclusion

The U.S. Aging-in-Place Medical Devices Market Size & Share is positioned for strong expansion from approximately USD 35.25 billion in 2025 to USD 86.96 billion by 2035, representing a 9.45% CAGR during 2026–2035.

The market’s long-term strength is supported by an unusually durable combination of demographic growth, consumer preference, chronic disease prevalence, fall risk, caregiver shortages, hospital capacity pressure, Medicare economics, technological improvement, and the continuing migration of healthcare activity into the home.

The most attractive growth opportunities will occur in connected chronic disease monitoring, automatic fall detection, mobile personal emergency response, wearable physiological sensing, advanced mobility systems, home respiratory technology, caregiver-support platforms, medication adherence, and AI-supported population monitoring.

Regional opportunity will remain concentrated in the South because of population scale and senior migration, while the West should record the fastest technology-led expansion. The Northeast will remain a high-value market for evidence-driven adoption, and the Midwest will provide stable demand supported by mature provider networks and rural home-care requirements.

Florida, California, Texas, New York, Pennsylvania, Ohio, Illinois, Michigan, North Carolina, Arizona, Georgia, New Jersey, Massachusetts, Virginia, and Washington will remain especially important state-level opportunities. Maine, Vermont, West Virginia, Idaho, and other smaller markets are strategically relevant because high senior concentration or rapid aging creates disproportionate demand relative to population size.

For market participants, the central strategic question is no longer whether Americans will increasingly need technology to remain independent at home. The more important question is which technologies can become part of reimbursable or economically justified healthcare workflows.

Companies that combine reliable medical devices with senior-centered design, passive monitoring, connectivity, caregiver engagement, clinical integration, service infrastructure, and defensible health-economic evidence will be best positioned to define the U.S. aging-in-place medical devices industry through 2035.

 

TABLE OF CONTENT

1. U.S. Aging-in-Place Medical Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market Sizing, Triangulation & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Aging-in-Place Medical Device Manufacturers
1.6.2. Component, Sensor and Contract Manufacturing Suppliers
1.6.3. Durable Medical Equipment Suppliers and Distributors
1.6.4. Hospitals, Health Systems and Integrated Delivery Networks
1.6.5. Home Health and Post-Acute Care Providers
1.6.6. Medicare Advantage and Managed-Care Organizations
1.6.7. Senior Living and Community-Based Aging Services Providers
1.6.8. Older Adults, Family Caregivers and Care Coordinators
1.6.9. CMS, FDA and State-Level Regulatory Stakeholders

What this section provides: This section defines the aging-in-place medical devices market boundary, included and excluded device categories, research methodology, assumptions, and stakeholder ecosystem so clients understand how the U.S. market is measured and validated.

2. U.S. Aging-in-Place Medical Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. U.S. Population Age 65+ and Aging-in-Place Demand Outlook
2.8. High-Growth Opportunity Areas
2.9. Priority Device Categories and Commercial White Spaces

What this section provides: This section gives decision-makers a concise view of market size, growth trajectory, demographic demand, high-growth device categories, competitive intensity, and priority opportunities across the U.S. aging-in-place medical devices ecosystem.

3. U.S. Aging-in-Place Medical Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rapid Expansion of the U.S. Population Age 65 and Above
3.1.2. Strong Consumer Preference to Age Safely at Home
3.1.3. Rising Prevalence of Chronic Disease and Multimorbidity
3.1.4. High Fall Incidence and Loss-of-Independence Risk
3.1.5. Growth of Home-Based and Post-Acute Care Models
3.1.6. Medicare Advantage Expansion and Value-Based Care Incentives
3.1.7. Caregiver Shortages and Growing Demand for Technology-Enabled Support
3.1.8. Increasing Adoption of Remote Patient Monitoring and Connected Medical Devices
3.2. Restraints and Their Impact Analysis
3.2.1. Fragmented Reimbursement Across Aging-in-Place Device Categories
3.2.2. High Out-of-Pocket Costs for Non-Covered Devices
3.2.3. Limited Digital Literacy Among Selected Older-Adult Populations
3.2.4. Device Abandonment, Adherence and Usability Challenges
3.2.5. Cybersecurity and Data Privacy Concerns
3.2.6. Rural Broadband and Connectivity Constraints
3.3. Opportunities and Their Impact Analysis
3.3.1. AI-Assisted Fall Prediction and Passive Monitoring
3.3.2. Connected Chronic Disease Management at Home
3.3.3. Medicare Advantage-Funded Home Safety and Monitoring Programs
3.3.4. Hospital-at-Home and Early Discharge Device Programs
3.3.5. Smart Mobility and Advanced Patient Transfer Technologies
3.3.6. Integrated Caregiver Monitoring and Alert Platforms
3.3.7. Rural Aging and Remote Clinical Monitoring Opportunities
3.4. Challenges and Their Impact Analysis
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Aging-in-Place Clinical Workflow Economics Analysis
3.7. Home Healthcare Device Adoption Economics
3.8. Total Cost of Care and Institutionalization Avoidance Analysis
3.9. Senior Usability and Human-Factors Analysis
3.10. Caregiver Workflow and Technology Burden Analysis

What this section provides: This section explains the demographic, clinical, reimbursement, caregiving, technological, and economic forces shaping market demand while helping clients assess adoption drivers, commercial opportunities, and execution risks.

4. U.S. Aging-in-Place Medical Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Durable Medical Equipment Distribution Ecosystem
4.6. Impact of Digitalization and Connected Home Care
4.7. Application & Innovation Landscape
4.8. FDA Regulatory Framework Analysis
4.9. CMS Medicare Coverage and Reimbursement Landscape
4.10. Medicare Advantage Supplemental Benefit Environment
4.11. Medicaid Home- and Community-Based Services Influence
4.12. Remote Patient Monitoring Reimbursement Environment
4.13. DMEPOS Coverage and Competitive Bidding Considerations
4.14. Import/Export Restrictions & Tariff Impact
4.15. U.S. Government Healthy Aging and Home-Based Care Initiatives
4.16. Cybersecurity, HIPAA and Connected Device Data Governance
4.17. Impact of Escalating Geopolitical and Supply-Chain Tensions
4.18. Health System and Payer Value-Analysis Decision Framework

What this section provides: This section gives clients a comprehensive view of regulation, reimbursement, pricing, supply chains, digital adoption, Medicare and Medicaid dynamics, cybersecurity, and the external environment affecting U.S. aging-in-place device commercialization.

5. U.S. Aging-in-Place Medical Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Connected Monitoring and Chronic-Care Devices
5.1.2.1. Blood Pressure Monitoring Devices
5.1.2.2. Continuous and Conventional Glucose Monitoring Devices
5.1.2.3. Pulse Oximeters
5.1.2.4. ECG and Cardiac Monitoring Devices
5.1.2.5. Connected Weight Scales
5.1.2.6. Multi-Parameter Remote Monitoring Devices
5.1.2.7. Home Diagnostic and Vital-Sign Monitoring Systems
5.1.3. Mobility, Transfer and Positioning Devices
5.1.3.1. Walkers and Rollators
5.1.3.2. Canes and Crutches
5.1.3.3. Manual Wheelchairs
5.1.3.4. Power Wheelchairs
5.1.3.5. Mobility Scooters
5.1.3.6. Patient Lifts and Transfer Systems
5.1.3.7. Pressure-Relief Seating and Positioning Systems
5.1.4. Fall Detection and Personal Emergency Response Devices
5.1.4.1. Home-Based PERS Devices
5.1.4.2. Mobile PERS Devices
5.1.4.3. Automatic Fall Detection Wearables
5.1.4.4. GPS-Enabled Emergency Devices
5.1.4.5. Passive In-Home Fall and Activity Sensors
5.1.4.6. Caregiver Alert and Emergency Communication Devices
5.1.5. Home Respiratory and Therapeutic Devices
5.1.5.1. CPAP and Bilevel Devices
5.1.5.2. Oxygen Concentrators
5.1.5.3. Nebulizers
5.1.5.4. Home Ventilatory Support Devices
5.1.5.5. Airway Clearance Devices
5.1.5.6. Home Infusion and Selected Therapeutic Equipment
5.1.6. Medication, Daily-Living and Safety Support Devices
5.1.6.1. Connected Medication Dispensers
5.1.6.2. Medication Reminder Devices
5.1.6.3. Bathroom Safety and Transfer Devices
5.1.6.4. Bedside Safety and Support Equipment
5.1.6.5. Pressure Injury Prevention Devices
5.1.6.6. Other Independence-Enabling Medical Devices

What this section provides: This section identifies the aging-in-place device categories generating the largest revenue contribution and strongest growth, with detailed analysis of connected monitoring, mobility, safety, respiratory, therapeutic, and independence-support products.

6. U.S. Aging-in-Place Medical Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Fall Prevention and Emergency Response
6.1.2.1. Fall Detection
6.1.2.2. Emergency Communication
6.1.2.3. Location Tracking and Wandering Management
6.1.2.4. Transfer and Mobility Safety
6.1.3. Chronic Disease Monitoring and Management
6.1.3.1. Diabetes Management
6.1.3.2. Cardiovascular and Hypertension Management
6.1.3.3. Respiratory Disease Management
6.1.3.4. Heart Failure Monitoring
6.1.3.5. Multimorbidity and General Remote Monitoring
6.1.4. Mobility and Activities-of-Daily-Living Support
6.1.4.1. Ambulation Support
6.1.4.2. Wheelchair and Powered Mobility
6.1.4.3. Patient Transfer and Repositioning
6.1.4.4. Bathroom and Personal-Care Assistance
6.1.5. Post-Acute Recovery and Home Rehabilitation
6.1.5.1. Post-Hospital Discharge Monitoring
6.1.5.2. Orthopedic Recovery
6.1.5.3. Stroke and Neurological Rehabilitation
6.1.5.4. Cardiopulmonary Recovery
6.1.5.5. Home-Based Rehabilitation Support
6.1.6. Cognitive, Medication and Caregiver Support
6.1.6.1. Medication Adherence
6.1.6.2. Cognitive Decline and Dementia Support
6.1.6.3. Caregiver Monitoring
6.1.6.4. Behavioral and Activity Change Detection

What this section provides: This section helps clients understand demand by use case and identify applications where aging demographics, fall risk, chronic disease, rehabilitation requirements, functional decline, and caregiver burden are driving device adoption.

7. U.S. Aging-in-Place Medical Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Older Adults Living Independently and Family Caregivers
7.1.2.1. Independent Older Adults
7.1.2.2. Frail and Mobility-Limited Older Adults
7.1.2.3. Adults With Multiple Chronic Conditions
7.1.2.4. Family and Informal Caregivers
7.1.3. Home Health Agencies and Post-Acute Providers
7.1.3.1. Medicare-Certified Home Health Agencies
7.1.3.2. Home Rehabilitation Providers
7.1.3.3. Home Respiratory and DME Service Providers
7.1.3.4. Transitional and Post-Acute Care Programs
7.1.4. Hospitals, Health Systems and Physician Groups
7.1.4.1. Integrated Delivery Networks
7.1.4.2. Hospital-at-Home Programs
7.1.4.3. Primary Care and Geriatric Practices
7.1.4.4. Specialty Chronic-Care Practices
7.1.5. Medicare Advantage, Medicaid and Managed-Care Organizations
7.1.5.1. Medicare Advantage Plans
7.1.5.2. Medicaid Managed-Care Organizations
7.1.5.3. Accountable and Value-Based Care Organizations
7.1.6. Senior Living, Community-Based Care and Aging Services Organizations
7.1.6.1. Independent Living Communities
7.1.6.2. Continuing Care Retirement Communities
7.1.6.3. Area Agencies on Aging and Community Programs
7.1.6.4. PACE and Community-Based Aging Programs

What this section provides: This section explains which customer groups are expected to drive aging-in-place device purchasing, reimbursement, deployment, utilization, and recurring connected-care demand.

8. U.S. Aging-in-Place Medical Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Non-Connected Mechanical and Assistive Technologies
8.1.2.1. Manual Mobility Technologies
8.1.2.2. Mechanical Transfer Technologies
8.1.2.3. Positioning and Pressure-Management Technologies
8.1.3. Sensor-Based and Passive Monitoring Technologies
8.1.3.1. Motion and Activity Sensors
8.1.3.2. Pressure and Bed-Exit Sensors
8.1.3.3. Environmental and Room-Based Sensors
8.1.3.4. Physiological Sensors
8.1.4. Wearable Medical and Safety Technologies
8.1.4.1. Wearable Fall Detection
8.1.4.2. Wearable Cardiac Monitoring
8.1.4.3. Continuous Glucose Sensors
8.1.4.4. Multi-Parameter Wearable Biosensors
8.1.4.5. GPS-Enabled Safety Wearables
8.1.5. Connected Clinical Monitoring Technologies
8.1.5.1. Bluetooth-Connected Devices
8.1.5.2. Cellular-Connected Devices
8.1.5.3. Wi-Fi-Connected Home Medical Devices
8.1.5.4. Remote Monitoring Hubs and Gateways
8.1.6. AI-Assisted and Predictive Aging-in-Place Technologies
8.1.6.1. AI-Based Fall Risk Prediction
8.1.6.2. Deterioration and Anomaly Detection
8.1.6.3. Predictive Mobility and Frailty Analytics
8.1.6.4. AI-Assisted Caregiver and Clinical Prioritization

What this section provides: This section evaluates the technology platforms transforming aging-in-place care, including mechanical assistive equipment, passive sensing, wearables, connected medical devices, and predictive AI-enabled monitoring.

9. U.S. Aging-in-Place Medical Devices Market: Commercial Access, Reimbursement & Procurement Analysis

9.1. Overview
9.2. Medicare Fee-for-Service Coverage Pathways
9.3. Medicare Advantage Coverage and Supplemental Benefits
9.4. Medicaid and HCBS Funding Pathways
9.5. DMEPOS Reimbursement and Supplier Economics
9.6. Remote Patient Monitoring Reimbursement Pathways
9.7. Health System and IDN Procurement
9.8. Home Health Agency Procurement
9.9. Payer-Sponsored Device Deployment
9.10. DME Distributor and Specialty Supplier Channel
9.11. Retail and Direct-to-Consumer Channel
9.12. E-Commerce and Digital Health Distribution
9.13. Employer, Veteran and Community-Based Funding Pathways
9.14. Subscription and Device-as-a-Service Business Models
9.15. Value-Based Contracting and Outcomes-Linked Models
9.16. Procurement Decision Criteria
9.16.1. Clinical Evidence
9.16.2. Total Cost of Care Impact
9.16.3. Ease of Installation and Patient Setup
9.16.4. Device Adherence and Senior Usability
9.16.5. Connectivity and Interoperability
9.16.6. Service, Logistics and Technical Support
9.16.7. Cybersecurity and Data Governance

What this section provides: This section explains how aging-in-place medical devices reach U.S. patients through Medicare, Medicare Advantage, Medicaid, DME suppliers, health systems, home health providers, retail channels, and direct-to-consumer models, without creating an additional formal market segmentation.

10. U.S. Aging-in-Place Medical Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Population Age 65+ and Senior Demographic Analysis
10.1.4. Regional Chronic Disease, Fall Risk and Functional Limitation Analysis
10.1.5. Regional Home Health, Medicare and Managed-Care Ecosystem
10.1.6. Regional Aging-in-Place Technology Adoption Analysis
10.1.7. Regional Reimbursement, Procurement and Distribution Dynamics
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Aging-in-Place Device Key Manufacturers and Commercial Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Reimbursement, Procurement and Route-to-Market Analysis
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Aging-in-Place Device Key Manufacturers and Commercial Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Reimbursement, Procurement and Route-to-Market Analysis
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Aging-in-Place Device Key Manufacturers and Commercial Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Reimbursement, Procurement and Route-to-Market Analysis
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Aging-in-Place Device Key Manufacturers and Commercial Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Reimbursement, Procurement and Route-to-Market Analysis
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis

What this section provides: This section delivers detailed four-region and all-state analysis, helping clients identify senior-population concentrations, aging-in-place adoption hotspots, payer and provider ecosystems, rural-access opportunities, and priority state-level commercial markets.

11. U.S. Aging-in-Place Medical Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Benchmarking
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players
11.4. Competitive Strategy Analysis
11.4.1. Product Portfolio Breadth
11.4.2. Clinical Evidence and Regulatory Position
11.4.3. Medicare and Payer Access
11.4.4. DME and Home-Care Distribution Reach
11.4.5. Connectivity and Software Capabilities
11.4.6. Senior Usability and Human-Factors Differentiation
11.4.7. Partnerships, Acquisitions and Ecosystem Expansion
11.5. Company Profiles
11.5.1. Abbott Laboratories
11.5.2. Medtronic
11.5.3. Dexcom
11.5.4. ResMed
11.5.5. Baxter International
11.5.6. Philips
11.5.7. Masimo
11.5.8. OMRON Healthcare
11.5.9. Insulet Corporation
11.5.10. Drive DeVilbiss Healthcare
11.5.11. Invacare
11.5.12. Sunrise Medical
11.5.13. Permobil
11.5.14. Pride Mobility Products
11.5.15. Stryker
11.5.16. Arjo
11.5.17. Savaria
11.5.18. Connect America
11.5.19. Medical Guardian
11.5.20. ADT Health
11.5.21. Tunstall Healthcare
11.5.22. Lively
11.5.23. BioIntelliSense
11.5.24. Withings Health Solutions
11.6. Company Profile Coverage Framework
11.6.1. Company Overview
11.6.2. Aging-in-Place Product Portfolio
11.6.3. U.S. Market Strategy
11.6.4. Revenue and Financial Positioning
11.6.5. Technology and Innovation Pipeline
11.6.6. FDA and Regulatory Updates
11.6.7. Payer, Provider and Channel Partnerships
11.6.8. Mergers, Acquisitions and Strategic Investments
11.6.9. Recent Developments

What this section provides: This section gives clients competitor benchmarking, market-share visibility, product positioning, distribution strength, reimbursement exposure, innovation direction, and strategic intelligence on major aging-in-place medical device companies.

12. U.S. Aging-in-Place Medical Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. AI-Assisted Fall Prediction
12.2.2. Passive Ambient Monitoring
12.2.3. Continuous Multi-Parameter Biosensing
12.2.4. Smart Mobility and Robotic Assistance
12.2.5. Connected Medication Management
12.2.6. Voice-Enabled Senior Assistance
12.2.7. Predictive Frailty and Functional Decline Analytics
12.2.8. Interoperable Home Monitoring Ecosystems
12.3. Evolution of Medicare and Managed-Care Funding
12.4. Aging Demographic Impact Through 2035
12.5. Hospital-at-Home and Home-Based Care Expansion
12.6. Emerging Business Trends
12.7. Business Opportunities for Startups and Existing Players
12.8. Investment Prioritization Matrix
12.9. Technology Adoption Roadmap, 2026–2035
12.10. High-Growth State and Regional Opportunity Matrix

What this section provides: This section prepares clients for future technology shifts, demographic change, evolving reimbursement, market structure changes, investment opportunities, and alternative adoption scenarios through 2035.

13. U.S. Aging-in-Place Medical Devices Market: Strategic Recommendations

13.1. Recommendations for Medical Device Manufacturers
13.2. Recommendations for Remote Monitoring and Digital Health Companies
13.3. Recommendations for Hospitals and Health Systems
13.4. Recommendations for Home Health and Post-Acute Providers
13.5. Recommendations for Medicare Advantage and Managed-Care Organizations
13.6. Recommendations for DME Suppliers and Distribution Partners
13.7. Recommendations for Senior Living and Community-Based Care Organizations
13.8. Recommendations for Investors and Private Equity Firms
13.9. Recommendations for New Entrants and Startups
13.10. U.S. Go-to-Market Strategy Considerations
13.11. Reimbursement and Market Access Strategy
13.12. Product Positioning and Portfolio Expansion Guidance
13.13. Senior-Centered Product Design and Usability Strategy
13.14. Partnership and Channel Development Strategy
13.15. State Prioritization and Geographic Expansion Strategy

What this section provides: This section converts market intelligence into actionable strategy for product development, reimbursement planning, channel expansion, geographic prioritization, investment decisions, senior-centered design, and competitive differentiation.

14. U.S. Aging-in-Place Medical Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Market Definition and Boundary Limitation
14.3. Data Use Limitation
14.4. Forecasting Limitation
14.5. State-Level Estimation Limitation
14.6. Reimbursement and Regulatory Information Limitation
14.7. Legal Disclaimer
14.8. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s scope, market-definition boundaries, state-level estimation methodology, legal limitations, data-use terms, reimbursement considerations, and forecasting assumptions.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Aging-in-Place Medical Devices Market: Market Definition and Scope
TABLE 3: U.S. Aging-in-Place Medical Devices Market: Research Methodology Framework
TABLE 4: U.S. Aging-in-Place Medical Devices Market: Key Assumptions
TABLE 5: U.S. Aging-in-Place Medical Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Aging-in-Place Medical Devices Market: Stakeholder Analysis
TABLE 7: U.S. Aging-in-Place Medical Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Aging-in-Place Medical Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Aging-in-Place Medical Devices Market: Market Attractiveness Index
TABLE 10: U.S. Aging-in-Place Medical Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Aging-in-Place Medical Devices Market: Base Year Market Positioning, 2025 (US$ Billion)
TABLE 12: U.S. Aging-in-Place Medical Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Aging-in-Place Medical Devices Market: High-Growth Opportunity Areas
TABLE 14: U.S. Aging-in-Place Medical Devices Market: Drivers; Impact Analysis
TABLE 15: U.S. Aging-in-Place Medical Devices Market: Restraints; Impact Analysis
TABLE 16: U.S. Aging-in-Place Medical Devices Market: Opportunities; Impact Analysis
TABLE 17: U.S. Aging-in-Place Medical Devices Market: Challenges; Impact Analysis
TABLE 18: U.S. Aging-in-Place Medical Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 19: U.S. Aging-in-Place Medical Devices Market: Aging-in-Place Clinical Workflow Economics Matrix
TABLE 20: U.S. Aging-in-Place Medical Devices Market: Home Healthcare Device Adoption Economics
TABLE 21: U.S. Aging-in-Place Medical Devices Market: Total Cost of Care and Institutionalization Avoidance Matrix
TABLE 22: U.S. Aging-in-Place Medical Devices Market: Senior Usability and Human-Factors Matrix
TABLE 23: U.S. Aging-in-Place Medical Devices Market: Caregiver Workflow and Technology Burden Analysis
TABLE 24: U.S. Aging-in-Place Medical Devices Market: PESTEL Analysis
TABLE 25: U.S. Aging-in-Place Medical Devices Market: Porter’s Five Forces Analysis
TABLE 26: U.S. Aging-in-Place Medical Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 27: U.S. Aging-in-Place Medical Devices Market: Value Chain Analysis
TABLE 28: U.S. Aging-in-Place Medical Devices Market: Supply Chain Analysis
TABLE 29: U.S. Aging-in-Place Medical Devices Market: DME Distribution Ecosystem
TABLE 30: U.S. Aging-in-Place Medical Devices Market: Digitalization and Connected Home Care Impact
TABLE 31: U.S. Aging-in-Place Medical Devices Market: FDA Regulatory Framework Analysis
TABLE 32: U.S. Aging-in-Place Medical Devices Market: CMS Medicare Coverage and Reimbursement Landscape
TABLE 33: U.S. Aging-in-Place Medical Devices Market: Medicare Advantage and Medicaid HCBS Landscape
TABLE 34: U.S. Aging-in-Place Medical Devices Market: Remote Patient Monitoring and DMEPOS Reimbursement Landscape
TABLE 35: U.S. Aging-in-Place Medical Devices Market: Cybersecurity, Data Governance and Procurement Decision Framework
TABLE 36: U.S. Aging-in-Place Medical Devices Market: Product Category Snapshot, 2025
TABLE 37: Segment Dashboard; Definition and Scope, by Product Category
TABLE 38: U.S. Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 39: U.S. Aging-in-Place Medical Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 40: Connected Monitoring and Chronic-Care Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: Mobility, Transfer and Positioning Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: Fall Detection and Personal Emergency Response Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: Home Respiratory and Therapeutic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: Medication, Daily-Living and Safety Support Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Aging-in-Place Medical Devices Market: Application Snapshot, 2025
TABLE 46: Segment Dashboard; Definition and Scope, by Application
TABLE 47: U.S. Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 48: U.S. Aging-in-Place Medical Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 49: Fall Prevention and Emergency Response Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: Chronic Disease Monitoring and Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: Mobility and Activities-of-Daily-Living Support Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: Post-Acute Recovery and Home Rehabilitation Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: Cognitive, Medication and Caregiver Support Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Aging-in-Place Medical Devices Market: End User Snapshot, 2025
TABLE 55: Segment Dashboard; Definition and Scope, by End User
TABLE 56: U.S. Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 57: U.S. Aging-in-Place Medical Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 58: Older Adults Living Independently and Family Caregivers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: Home Health Agencies and Post-Acute Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: Hospitals, Health Systems and Physician Groups Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: Medicare Advantage, Medicaid and Managed-Care Organizations Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: Senior Living, Community-Based Care and Aging Services Organizations Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Aging-in-Place Medical Devices Market: Technology Type Snapshot, 2025
TABLE 64: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 65: U.S. Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 66: U.S. Aging-in-Place Medical Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 67: Non-Connected Mechanical and Assistive Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: Sensor-Based and Passive Monitoring Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: Wearable Medical and Safety Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: Connected Clinical Monitoring Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: AI-Assisted and Predictive Aging-in-Place Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Aging-in-Place Medical Devices Market: Medicare Fee-for-Service Coverage Pathways
TABLE 73: U.S. Aging-in-Place Medical Devices Market: Medicare Advantage Supplemental Benefit Landscape
TABLE 74: U.S. Aging-in-Place Medical Devices Market: Medicaid and HCBS Funding Pathways
TABLE 75: U.S. Aging-in-Place Medical Devices Market: DMEPOS Reimbursement and Supplier Economics
TABLE 76: U.S. Aging-in-Place Medical Devices Market: Remote Patient Monitoring Reimbursement Pathways
TABLE 77: U.S. Aging-in-Place Medical Devices Market: Health System and Home Health Procurement Matrix
TABLE 78: U.S. Aging-in-Place Medical Devices Market: Payer-Sponsored Device Deployment Models
TABLE 79: U.S. Aging-in-Place Medical Devices Market: DME, Retail and Direct-to-Consumer Channel Analysis
TABLE 80: U.S. Aging-in-Place Medical Devices Market: Subscription and Device-as-a-Service Business Models
TABLE 81: U.S. Aging-in-Place Medical Devices Market: Procurement Decision Criteria Matrix
TABLE 82: U.S. Aging-in-Place Medical Devices Market: Regional Snapshot, 2025
TABLE 83: Segment Dashboard; Definition and Scope, by Region
TABLE 84: U.S. Aging-in-Place Medical Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 85: U.S. Aging-in-Place Medical Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 86: West Region U.S. Aging-in-Place Medical Devices Market: Regional Overview and Trends
TABLE 87: West Region U.S. Aging-in-Place Medical Devices Market: Key Manufacturers and Commercial Ecosystem
TABLE 88: West Region U.S. Aging-in-Place Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 89: West Region U.S. Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 90: West Region U.S. Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 91: West Region U.S. Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 92: West Region U.S. Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Route-to-Market Analysis
TABLE 94: California Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 95: California Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 96: California Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 97: California Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 98: California Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 99: California Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 100: Washington Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 101: Washington Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 102: Washington Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 103: Washington Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 104: Washington Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 105: Washington Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 106: Arizona Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 107: Arizona Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 108: Arizona Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 109: Arizona Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 110: Arizona Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 111: Arizona Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 112: Colorado Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 113: Colorado Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 114: Colorado Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 115: Colorado Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 116: Colorado Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 117: Colorado Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 118: Oregon Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 119: Oregon Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 120: Oregon Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 121: Oregon Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 122: Oregon Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 123: Oregon Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 124: Utah Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 125: Utah Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 126: Utah Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 127: Utah Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 128: Utah Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 129: Utah Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 130: Nevada Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 131: Nevada Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 132: Nevada Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 133: Nevada Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 134: Nevada Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 135: Nevada Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 136: New Mexico Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 137: New Mexico Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 138: New Mexico Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 139: New Mexico Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 140: New Mexico Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 141: New Mexico Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 142: Idaho Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 143: Idaho Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 144: Idaho Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 145: Idaho Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 146: Idaho Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 147: Idaho Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 148: Montana Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 149: Montana Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 150: Montana Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 151: Montana Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 152: Montana Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 153: Montana Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 154: Wyoming Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 155: Wyoming Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 156: Wyoming Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 157: Wyoming Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 158: Wyoming Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 159: Wyoming Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 160: Alaska Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 161: Alaska Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 162: Alaska Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 163: Alaska Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 164: Alaska Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 165: Alaska Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 166: Hawaii Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 167: Hawaii Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 168: Hawaii Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 169: Hawaii Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 170: Hawaii Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 171: Hawaii Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 172: Northeast Region U.S. Aging-in-Place Medical Devices Market: Regional Overview and Trends
TABLE 173: Northeast Region U.S. Aging-in-Place Medical Devices Market: Key Manufacturers and Commercial Ecosystem
TABLE 174: Northeast Region U.S. Aging-in-Place Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 175: Northeast Region U.S. Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 176: Northeast Region U.S. Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 177: Northeast Region U.S. Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 178: Northeast Region U.S. Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 179: Northeast Region U.S. Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Route-to-Market Analysis
TABLE 180: New York Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 181: New York Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 182: New York Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 183: New York Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 184: New York Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 185: New York Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 186: Massachusetts Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 187: Massachusetts Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 188: Massachusetts Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 189: Massachusetts Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 190: Massachusetts Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 191: Massachusetts Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 192: New Jersey Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 193: New Jersey Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 194: New Jersey Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 195: New Jersey Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 196: New Jersey Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 197: New Jersey Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 198: Pennsylvania Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 199: Pennsylvania Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 200: Pennsylvania Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 201: Pennsylvania Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 202: Pennsylvania Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 203: Pennsylvania Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 204: Connecticut Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 205: Connecticut Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 206: Connecticut Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 207: Connecticut Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 208: Connecticut Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 209: Connecticut Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 210: Maine Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 211: Maine Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 212: Maine Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 213: Maine Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 214: Maine Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 215: Maine Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 216: Vermont Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 217: Vermont Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 218: Vermont Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 219: Vermont Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 220: Vermont Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 221: Vermont Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 222: New Hampshire Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 223: New Hampshire Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 224: New Hampshire Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 225: New Hampshire Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 226: New Hampshire Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 227: New Hampshire Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 228: Rhode Island Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 229: Rhode Island Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 230: Rhode Island Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 231: Rhode Island Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 232: Rhode Island Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 233: Rhode Island Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 234: Delaware Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 235: Delaware Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 236: Delaware Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 237: Delaware Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 238: Delaware Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 239: Delaware Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 240: South Region U.S. Aging-in-Place Medical Devices Market: Regional Overview and Trends
TABLE 241: South Region U.S. Aging-in-Place Medical Devices Market: Key Manufacturers and Commercial Ecosystem
TABLE 242: South Region U.S. Aging-in-Place Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 243: South Region U.S. Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 244: South Region U.S. Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 245: South Region U.S. Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 246: South Region U.S. Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 247: South Region U.S. Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Route-to-Market Analysis
TABLE 248: Texas Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 249: Texas Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 250: Texas Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 251: Texas Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 252: Texas Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 253: Texas Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 254: Florida Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 255: Florida Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 256: Florida Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 257: Florida Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 258: Florida Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 259: Florida Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 260: Georgia Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 261: Georgia Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 262: Georgia Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 263: Georgia Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 264: Georgia Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 265: Georgia Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 266: North Carolina Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 267: North Carolina Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 268: North Carolina Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 269: North Carolina Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 270: North Carolina Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 271: North Carolina Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 272: Tennessee Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 273: Tennessee Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 274: Tennessee Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 275: Tennessee Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 276: Tennessee Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 277: Tennessee Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 278: South Carolina Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 279: South Carolina Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 280: South Carolina Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 281: South Carolina Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 282: South Carolina Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 283: South Carolina Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 284: Alabama Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 285: Alabama Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 286: Alabama Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 287: Alabama Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 288: Alabama Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 289: Alabama Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 290: Mississippi Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 291: Mississippi Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 292: Mississippi Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 293: Mississippi Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 294: Mississippi Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 295: Mississippi Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 296: Louisiana Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 297: Louisiana Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 298: Louisiana Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 299: Louisiana Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 300: Louisiana Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 301: Louisiana Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 302: Arkansas Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 303: Arkansas Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 304: Arkansas Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 305: Arkansas Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 306: Arkansas Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 307: Arkansas Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 308: Kentucky Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 309: Kentucky Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 310: Kentucky Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 311: Kentucky Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 312: Kentucky Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 313: Kentucky Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 314: Oklahoma Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 315: Oklahoma Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 316: Oklahoma Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 317: Oklahoma Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 318: Oklahoma Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 319: Oklahoma Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 320: Virginia Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 321: Virginia Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 322: Virginia Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 323: Virginia Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 324: Virginia Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 325: Virginia Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 326: Maryland Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 327: Maryland Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 328: Maryland Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 329: Maryland Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 330: Maryland Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 331: Maryland Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 332: West Virginia Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 333: West Virginia Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 334: West Virginia Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 335: West Virginia Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 336: West Virginia Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 337: West Virginia Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 338: Midwest Region U.S. Aging-in-Place Medical Devices Market: Regional Overview and Trends
TABLE 339: Midwest Region U.S. Aging-in-Place Medical Devices Market: Key Manufacturers and Commercial Ecosystem
TABLE 340: Midwest Region U.S. Aging-in-Place Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 341: Midwest Region U.S. Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 342: Midwest Region U.S. Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 343: Midwest Region U.S. Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 344: Midwest Region U.S. Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 345: Midwest Region U.S. Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Route-to-Market Analysis
TABLE 346: Illinois Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 347: Illinois Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 348: Illinois Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 349: Illinois Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 350: Illinois Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 351: Illinois Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 352: Ohio Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 353: Ohio Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 354: Ohio Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 355: Ohio Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 356: Ohio Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 357: Ohio Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 358: Michigan Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 359: Michigan Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 360: Michigan Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 361: Michigan Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 362: Michigan Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 363: Michigan Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 364: Minnesota Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 365: Minnesota Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 366: Minnesota Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 367: Minnesota Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 368: Minnesota Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 369: Minnesota Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 370: Indiana Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 371: Indiana Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 372: Indiana Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 373: Indiana Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 374: Indiana Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 375: Indiana Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 376: Wisconsin Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 377: Wisconsin Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 378: Wisconsin Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 379: Wisconsin Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 380: Wisconsin Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 381: Wisconsin Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 382: Missouri Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 383: Missouri Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 384: Missouri Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 385: Missouri Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 386: Missouri Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 387: Missouri Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 388: Iowa Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 389: Iowa Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 390: Iowa Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 391: Iowa Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 392: Iowa Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 393: Iowa Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 394: Kansas Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 395: Kansas Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 396: Kansas Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 397: Kansas Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 398: Kansas Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 399: Kansas Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 400: Nebraska Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 401: Nebraska Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 402: Nebraska Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 403: Nebraska Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 404: Nebraska Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 405: Nebraska Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 406: North Dakota Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 407: North Dakota Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 408: North Dakota Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 409: North Dakota Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 410: North Dakota Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 411: North Dakota Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 412: South Dakota Aging-in-Place Medical Devices Market: State Market Snapshot, 2025
TABLE 413: South Dakota Aging-in-Place Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 414: South Dakota Aging-in-Place Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 415: South Dakota Aging-in-Place Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 416: South Dakota Aging-in-Place Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 417: South Dakota Aging-in-Place Medical Devices Market: Reimbursement, Procurement and Aging-in-Place Ecosystem Analysis
TABLE 418: U.S. Aging-in-Place Medical Devices Market: Competitive Landscape Snapshot, 2025
TABLE 419: U.S. Aging-in-Place Medical Devices Market: Key Company Market Share Analysis, 2025
TABLE 420: U.S. Aging-in-Place Medical Devices Market: Company Positioning Matrix
TABLE 421: U.S. Aging-in-Place Medical Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 422: U.S. Aging-in-Place Medical Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 423: Abbott Laboratories: Company Profile
TABLE 424: Medtronic: Company Profile
TABLE 425: Dexcom: Company Profile
TABLE 426: ResMed: Company Profile
TABLE 427: Baxter International: Company Profile
TABLE 428: Philips: Company Profile
TABLE 429: Masimo: Company Profile
TABLE 430: OMRON Healthcare: Company Profile
TABLE 431: Insulet Corporation: Company Profile
TABLE 432: Drive DeVilbiss Healthcare: Company Profile
TABLE 433: Invacare: Company Profile
TABLE 434: Sunrise Medical: Company Profile
TABLE 435: Permobil: Company Profile
TABLE 436: Pride Mobility Products: Company Profile
TABLE 437: Stryker: Company Profile
TABLE 438: Arjo: Company Profile
TABLE 439: Savaria: Company Profile
TABLE 440: Connect America: Company Profile
TABLE 441: Medical Guardian: Company Profile
TABLE 442: ADT Health: Company Profile
TABLE 443: Tunstall Healthcare: Company Profile
TABLE 444: Lively: Company Profile
TABLE 445: BioIntelliSense: Company Profile
TABLE 446: Withings Health Solutions: Company Profile
TABLE 447: U.S. Aging-in-Place Medical Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 448: U.S. Aging-in-Place Medical Devices Market: Disruptive Technologies Impact Matrix
TABLE 449: U.S. Aging-in-Place Medical Devices Market: Medicare and Managed-Care Evolution Outlook
TABLE 450: U.S. Aging-in-Place Medical Devices Market: Aging Demographic Impact Through 2035
TABLE 451: U.S. Aging-in-Place Medical Devices Market: Hospital-at-Home and Home-Based Care Expansion Outlook
TABLE 452: U.S. Aging-in-Place Medical Devices Market: Emerging Business Trends
TABLE 453: U.S. Aging-in-Place Medical Devices Market: Business Opportunities for Startups and Existing Players
TABLE 454: U.S. Aging-in-Place Medical Devices Market: Investment Prioritization and Technology Adoption Matrix
TABLE 455: Strategic Recommendations for Medical Device Manufacturers
TABLE 456: Strategic Recommendations for Remote Monitoring and Digital Health Companies
TABLE 457: Strategic Recommendations for Hospitals, Health Systems and Home Health Providers
TABLE 458: Strategic Recommendations for Medicare Advantage and Managed-Care Organizations
TABLE 459: Strategic Recommendations for DME Suppliers and Distribution Partners
TABLE 460: Strategic Recommendations for Investors, Private Equity Firms and New Entrants
TABLE 461: U.S. Aging-in-Place Medical Devices Market: Go-to-Market and Reimbursement Strategy Considerations
TABLE 462: U.S. Aging-in-Place Medical Devices Market: Product Positioning, Portfolio and Geographic Expansion Guidance
TABLE 463: U.S. Aging-in-Place Medical Devices Market: Scope and Market Boundary Limitation
TABLE 464: U.S. Aging-in-Place Medical Devices Market: Data Use Limitation
TABLE 465: U.S. Aging-in-Place Medical Devices Market: Forecasting and State-Level Estimation Limitation
TABLE 466: U.S. Aging-in-Place Medical Devices Market: Regulatory, Reimbursement and Legal Disclaimer
TABLE 467: U.S. Aging-in-Place Medical Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Aging-in-Place Medical Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Aging-in-Place Medical Device Stakeholder Ecosystem
FIGURE 4: U.S. Aging-in-Place Medical Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 5: U.S. Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 6: U.S. Aging-in-Place Medical Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 7: Market Attractiveness and High-Growth Opportunity Map
FIGURE 8: U.S. Aging-in-Place Medical Devices Market Dynamics
FIGURE 9: U.S. Population Aging and Device Demand Framework
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Aging-in-Place Clinical Workflow Economics Framework
FIGURE 12: Total Cost of Care and Institutionalization Avoidance Framework
FIGURE 13: Senior Usability and Caregiver Workflow Framework
FIGURE 14: PESTEL Analysis
FIGURE 15: Porter’s Five Forces Analysis
FIGURE 16: Value Chain Analysis
FIGURE 17: Supply Chain and DME Distribution Ecosystem
FIGURE 18: Medicare, Medicaid and DMEPOS Reimbursement Framework
FIGURE 19: Connected Home Care and Digitalization Landscape
FIGURE 20: Health System and Payer Procurement Decision Framework
FIGURE 21: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 22: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Connected Monitoring and Chronic-Care Devices Market Forecast, 2021–2035
FIGURE 24: Mobility, Transfer and Positioning Devices Market Forecast, 2021–2035
FIGURE 25: Fall Detection and Personal Emergency Response Devices Market Forecast, 2021–2035
FIGURE 26: Home Respiratory and Therapeutic Devices Market Forecast, 2021–2035
FIGURE 27: Medication, Daily-Living and Safety Support Devices Market Forecast, 2021–2035
FIGURE 28: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 29: Application Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 30: Fall Prevention and Emergency Response Market Forecast, 2021–2035
FIGURE 31: Chronic Disease Monitoring and Management Market Forecast, 2021–2035
FIGURE 32: Mobility and Activities-of-Daily-Living Support Market Forecast, 2021–2035
FIGURE 33: Post-Acute Recovery and Home Rehabilitation Market Forecast, 2021–2035
FIGURE 34: Cognitive, Medication and Caregiver Support Market Forecast, 2021–2035
FIGURE 35: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 36: End User Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 37: Older Adults and Family Caregivers Market Forecast, 2021–2035
FIGURE 38: Home Health Agencies and Post-Acute Providers Market Forecast, 2021–2035
FIGURE 39: Hospitals, Health Systems and Physician Groups Market Forecast, 2021–2035
FIGURE 40: Medicare Advantage, Medicaid and Managed-Care Organizations Market Forecast, 2021–2035
FIGURE 41: Senior Living and Community-Based Aging Services Market Forecast, 2021–2035
FIGURE 42: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 43: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 44: Non-Connected Mechanical and Assistive Technologies Market Forecast, 2021–2035
FIGURE 45: Sensor-Based and Passive Monitoring Technologies Market Forecast, 2021–2035
FIGURE 46: Wearable Medical and Safety Technologies Market Forecast, 2021–2035
FIGURE 47: Connected Clinical Monitoring Technologies Market Forecast, 2021–2035
FIGURE 48: AI-Assisted and Predictive Aging-in-Place Technologies Market Forecast, 2021–2035
FIGURE 49: Aging-in-Place Medical Device Coverage and Reimbursement Pathways
FIGURE 50: Medicare Advantage and Medicaid HCBS Access Framework
FIGURE 51: DMEPOS Supplier and Distribution Economics Framework
FIGURE 52: Remote Patient Monitoring Reimbursement Pathway
FIGURE 53: Aging-in-Place Medical Device Route-to-Market Framework
FIGURE 54: Value-Based Procurement and Outcomes-Linked Contracting Framework
FIGURE 55: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 56: Regional Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: West Region U.S. Aging-in-Place Medical Devices Market Share and Leading Players, 2025
FIGURE 58: West Region Market Share Analysis by State, 2025
FIGURE 59: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: West Region Senior Population, Home-Care and Aging-in-Place Opportunity Map
FIGURE 61: California Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Washington Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Arizona Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Colorado Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Oregon Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Utah Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Nevada Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: New Mexico Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Idaho Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Montana Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Wyoming Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Alaska Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Hawaii Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Northeast Region U.S. Aging-in-Place Medical Devices Market Share and Leading Players, 2025
FIGURE 75: Northeast Region Market Share Analysis by State, 2025
FIGURE 76: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Northeast Region Senior Population, Home-Care and Aging-in-Place Opportunity Map
FIGURE 78: New York Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Massachusetts Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: New Jersey Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Pennsylvania Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Connecticut Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Maine Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Vermont Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: New Hampshire Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Rhode Island Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Delaware Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: South Region U.S. Aging-in-Place Medical Devices Market Share and Leading Players, 2025
FIGURE 89: South Region Market Share Analysis by State, 2025
FIGURE 90: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: South Region Senior Population, Home-Care and Aging-in-Place Opportunity Map
FIGURE 92: Texas Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Florida Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Georgia Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: North Carolina Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Tennessee Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: South Carolina Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Alabama Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Mississippi Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Louisiana Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Arkansas Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Kentucky Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Oklahoma Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Virginia Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Maryland Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: West Virginia Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Midwest Region U.S. Aging-in-Place Medical Devices Market Share and Leading Players, 2025
FIGURE 108: Midwest Region Market Share Analysis by State, 2025
FIGURE 109: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Midwest Region Senior Population, Home-Care and Aging-in-Place Opportunity Map
FIGURE 111: Illinois Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Ohio Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Michigan Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Minnesota Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Indiana Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Wisconsin Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Missouri Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Iowa Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Kansas Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: Nebraska Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 121: North Dakota Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 122: South Dakota Aging-in-Place Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 123: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 124: Company Positioning Matrix
FIGURE 125: Key Player Product Portfolio Benchmarking
FIGURE 126: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 127: Aging-in-Place Medical Device Competitive Ecosystem
FIGURE 128: Key Player Technology and Commercial Positioning Map
FIGURE 129: Payer, Provider and DME Channel Partnership Landscape
FIGURE 130: Senior Usability and Connected-Care Competitive Benchmark
FIGURE 131: Future Market Scenario Analysis, 2026–2035
FIGURE 132: Disruptive Technologies Impact Matrix
FIGURE 133: AI-Assisted and Passive Monitoring Adoption Roadmap
FIGURE 134: Smart Mobility and Connected Home Care Opportunity Map
FIGURE 135: Medicare and Managed-Care Evolution Roadmap
FIGURE 136: Hospital-at-Home and Home-Based Care Expansion Roadmap
FIGURE 137: Predictive Frailty and Functional Decline Technology Roadmap
FIGURE 138: Emerging Business Trends Matrix
FIGURE 139: Investment Prioritization Matrix
FIGURE 140: Technology Adoption Roadmap, 2026–2035
FIGURE 141: Strategic Growth Roadmap for U.S. Aging-in-Place Medical Device Companies
FIGURE 142: Go-to-Market Strategy Framework
FIGURE 143: Reimbursement and Market Access Strategy Framework
FIGURE 144: Product Positioning and Portfolio Expansion Framework
FIGURE 145: Senior-Centered Product Design and Usability Framework
FIGURE 146: Partnership and Channel Development Strategy
FIGURE 147: State Prioritization and Geographic Expansion Framework
FIGURE 148: Report Scope, Market Boundary and Disclaimer Framework